Valencia, Calif — Advanced Bionics, a division of Sonova Holding AG, has named Gerhard Roehrlein 
as its new CEO and appointed Hansjurg Emch as its new group vice president medical on the Sonova Management Board.
Roehrlein first came to Advanced Bionics (AB) in 2010 after nearly 25 years with Siemens Medical. He originally served as chief technical officer, leading AB’s research, development, and technology initiatives. In this added position as AB’s CEO, Roehrlein will now be responsible for implementing long-term business strategies and directing the overall growth of the organization.
Roehrlein commented in the press release, "In my leadership roles at Advanced Bionics, I will continue our unwavering dedication to putting patients first by focusing on the quality and reliability of our products, as well as providing world-class services.”
Roehrlein was educated in his native Germany, where Siemens Medical is based. While at Siemens, he worked primarily within the company’s health care sector and held eight positions, six of which were at the vice president level, both in the United States and abroad.
In addition to the Roehrlein announcement, Sonova has added a new Management Board position. As the new group vice president medical on the board, Hansjurg Emch will be responsible for overseeing Sonova’s hearing implant segment, including AB and Phonak Acoustic Implants.
Emch has been working for 15 years in the health care sector, most recently serving as president of Synthes Spine, where he reportedly led the global spine division to significant sales growth.
SOURCE: Advanced Bionics
